SOST-Related Sclerosing Bone Dysplasia
Symptoms, Doctors, Treatments, Advances & More

Find a DoctorCondition OverviewLatest AdvancesClinical TrialsTreatments

SOST-Related Sclerosing Bone Dysplasia Overview

  • Definition
  • Causes
  • Prevalence
  • Inheritance
  • Top Doctors
  • Clinical Trials
  • Source Of Information
  • Latest Advances
Save information for later
Sign Up

Learn About SOST-Related Sclerosing Bone Dysplasia

What is the definition of SOST-Related Sclerosing Bone Dysplasia?

SOST-related sclerosing bone dysplasia is a disorder of bone development characterized by excessive bone formation (hyperostosis). As a result of hyperostosis, bones throughout the body are denser and wider than normal, particularly the bones of the skull. Affected individuals typically have an enlarged jaw with misaligned teeth. People with this condition may also have a sunken appearance of the middle of the face (midface hypoplasia), bulging eyes with shallow eye sockets (ocular proptosis), and a prominent forehead. People with this condition often experience headaches because increased thickness of the skull bones increases pressure on the brain. The excessive bone formation seen in this condition seems to occur throughout a person's life, so the skeletal features become more pronounced over time. However, the excessive bone growth may only occur in certain areas.

What are the causes of SOST-Related Sclerosing Bone Dysplasia?

SOST-related sclerosing bone dysplasia is caused by mutations in or near the SOST gene. The SOST gene provides instructions for making the protein sclerostin. Sclerostin is produced in osteocytes, which are a type of bone cell. The main function of sclerostin is to stop (inhibit) bone formation.

How prevalent is SOST-Related Sclerosing Bone Dysplasia?

SOST-related sclerosing bone dysplasia is a rare condition; its exact prevalence is unknown.

Is SOST-Related Sclerosing Bone Dysplasia an inherited disorder?

This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.

Who are the top SOST-Related Sclerosing Bone Dysplasia Local Doctors?
Elite in SOST-Related Sclerosing Bone Dysplasia
Eveline Boudin
Elite in SOST-Related Sclerosing Bone Dysplasia
Eveline Boudin
Antwerpen, VLG, BE 

Eveline Boudin practices in Antwerpen, Belgium. Ms. Boudin is rated as an Elite expert by MediFind in the treatment of SOST-Related Sclerosing Bone Dysplasia. Her top areas of expertise are SOST-Related Sclerosing Bone Dysplasia, Paget's Disease of Bone, Juvenile Primary Osteoporosis, and Melorheostosis.

Elite in SOST-Related Sclerosing Bone Dysplasia
Antoon H. Van Lierop
Elite in SOST-Related Sclerosing Bone Dysplasia
Antoon H. Van Lierop
Leiden, ZH, NL 

Antoon Van Lierop practices in Leiden, Netherlands. Van Lierop is rated as an Elite expert by MediFind in the treatment of SOST-Related Sclerosing Bone Dysplasia. Their top areas of expertise are SOST-Related Sclerosing Bone Dysplasia, Brachydactyly Mononen Type, Syndactyly, and Acromicric Dysplasia.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in SOST-Related Sclerosing Bone Dysplasia
Socrates E. Papapoulos
Elite in SOST-Related Sclerosing Bone Dysplasia
Socrates E. Papapoulos
Leiden, ZH, NL 

Socrates Papapoulos practices in Leiden, Netherlands. Mr. Papapoulos is rated as an Elite expert by MediFind in the treatment of SOST-Related Sclerosing Bone Dysplasia. His top areas of expertise are Postmenopausal Osteoporosis, Osteoporosis, SOST-Related Sclerosing Bone Dysplasia, Brachydactyly Mononen Type, and Vertebroplasty.

View All Doctors
What are the latest SOST-Related Sclerosing Bone Dysplasia Clinical Trials?
Match to trials
Find the right clinical trials for you in under a minute
Get started
View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: June 01, 2009
Published By: National Institutes of Health

What are the Latest Advances for SOST-Related Sclerosing Bone Dysplasia?
Clinical Characteristics and Management of Rare Metabolic Bone Diseases: An Audit of the Rare Metabolic Bone Disease Registry of India.
Clinical Characteristics and Management of Rare Metabolic Bone Diseases: An Audit of the Rare Metabolic Bone Disease Registry of India.
Journal: Calcified tissue international
Published: May 26, 2025
Novel Loss of Function Variant in SOST From Chinese Family Results in Sclerosteosis 1.
Novel Loss of Function Variant in SOST From Chinese Family Results in Sclerosteosis 1.
Journal: Molecular genetics & genomic medicine
Published: November 28, 2024
Tired of the same old research?
Check Latest Advances
Long-term clinical and bone mineral density changes of adult patients with sclerostin deficiency due to van Buchem disease: a follow-up study.
Long-term clinical and bone mineral density changes of adult patients with sclerostin deficiency due to van Buchem disease: a follow-up study.
Journal: JBMR plus
Published: October 03, 2024
View All Latest Advances
  1. Homepage
  2. SOST-Related Sclerosing Bone Dysplasia
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2025 All Rights Reserved